View Item 

Show simple item record

Expression of polycomb group protein EZH2 in nevi and melanoma

dc.contributor.authorMcHugh, Jonathan B.en_US
dc.contributor.authorFullen, Douglas R.en_US
dc.contributor.authorMa, Lingleien_US
dc.contributor.authorKleer, Celina G.en_US
dc.contributor.authorSu, Lyndon D.en_US
dc.date.accessioned2010-06-01T21:32:50Z
dc.date.available2010-06-01T21:32:50Z
dc.date.issued2007-08en_US
dc.identifier.citationMcHugh, Jonathan B.; Fullen, Douglas R.; Ma, Linglei; Kleer, Celina G.; Su, Lyndon D. (2007). "Expression of polycomb group protein EZH2 in nevi and melanoma." Journal of Cutaneous Pathology 34(8): 597-600. <http://hdl.handle.net/2027.42/74600>en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74600
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17640228&dopt=citationen_US
dc.format.extent334898 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsBlackwell Munksgaard 2007en_US
dc.titleExpression of polycomb group protein EZH2 in nevi and melanomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, Ann Arbor, MI, USAen_US
dc.identifier.pmid17640228en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74600/1/j.1600-0560.2006.00678.x.pdf
dc.identifier.doi10.1111/j.1600-0560.2006.00678.xen_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceLaibile G, Wolf A, Dorn R, et al. Mammalian homologues of the polycomb-group gene enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisae telomeres. EMBO J 1997; 16: 3219.en_US
dc.identifier.citedreferenceSimon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of polycomb and trithorax group complexes. Curr Opin Genet Dev 2002; 12: 210.en_US
dc.identifier.citedreferenceTang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 2004; 23: 5759.en_US
dc.identifier.citedreferenceBracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003; 22: 5323.en_US
dc.identifier.citedreferenceRaaphorst FM, van Kemenade FJ, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin’s disease. Am J Pathol 2000; 157: 709.en_US
dc.identifier.citedreferenceVarambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624.en_US
dc.identifier.citedreferenceKleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100: 11606.en_US
dc.identifier.citedreferenceRaaphorst FM, Meijer CJ, Fieret E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 2003; 5: 481.en_US
dc.identifier.citedreferenceSudo T, Utsunomiya T, Mimori K, et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 2005; 92: 1754.en_US
dc.identifier.citedreferenceArisan S, Buyuktuncer ED, Palavan-Unsal N, Caskurlu T, Cakir OO, Ergenekon E. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma. Urol Int 2005; 75: 252.en_US
dc.identifier.citedreferenceBachmann IM, Halvorsen OJ, Collett K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate and breast. J Clin Oncol 2006; 24: 268.en_US
dc.identifier.citedreferenceKirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as potential molecular target for human cancer therapy. Mol Cancer Ther 2003; 2: 113.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0560.2006.00678.x.pdf
Size:
327.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.